Therapeutic Use of Cannabis and Cannabinoids

作者
Michael Hsu,Arya Shah,Ayana Jordan,Mark S Gold,Kevin P. Hill
出处
期刊:JAMA [American Medical Association]
标识
DOI:10.1001/jama.2025.19433
摘要

Importance Approximately 27% of adults in the US and Canada report having ever used cannabis for medical purposes. An estimated 10.5% of the US population reports using cannabidiol (CBD), a chemical compound extracted from cannabis that does not have psychoactive effects, for therapeutic purposes. Observations Conditions for which cannabinoids have approval from the US Food and Drug Administration include HIV/AIDS–related anorexia, chemotherapy-induced nausea and vomiting, and certain pediatric seizure disorders. A meta-analysis of randomized clinical trials reported a small but significant reduction in nausea and vomiting from various causes (eg, chemotherapy, cancer) when comparing prescribed cannabinoids (eg, dronabinol, nabilone) with placebo or active comparators (eg, alizapride, chlorpromazine; standardized mean difference [SMD], −0.29 [95% CI, −0.39 to −0.18]). A meta-analysis of randomized clinical trials among patients with HIV/AIDS reported that cannabinoids had a moderate effect on increasing body weight compared with placebo (SMD, 0.57 [95% CI, 0.22 to 0.92]). Evidence-based guidelines do not recommend the use of inhaled or high-potency cannabis (≥10% or 10 mg Δ9-tetrahydrocannabinol [Δ9-THC]) for medical purposes. High-potency cannabis compared with low-potency cannabis use is associated with increased risk of psychotic symptoms (12.4% vs 7.1%) and generalized anxiety disorder (19.1% vs 11.6%). A meta-analysis of observational studies reported that 29% of individuals who used cannabis for medical purposes met criteria for cannabis use disorder. Daily inhaled cannabis use compared with nondaily use was associated with an increased risk of coronary heart disease (2.0% vs 0.9%), myocardial infarction (1.7% vs 1.3%), and stroke (2.6% vs 1.0%). Evidence from randomized clinical trials does not support the use of cannabis or cannabinoids for most conditions for which it is promoted, such as acute pain and insomnia. Before considering cannabis or cannabinoids for medical use, clinicians should consult applicable institutional, state, and national regulations; evaluate for drug-drug interactions; and assess for contraindications (eg, pregnancy) or conditions in which risks likely outweigh benefits (eg, schizophrenia or ischemic heart disease). For patients using cannabis or cannabinoids for treatment of medical conditions, clinicians should discuss harm reduction strategies, including avoiding concurrent use with alcohol or other central nervous system depressants such as benzodiazepines, using the lowest effective dose, and avoiding use when driving or operating machinery. Conclusions and Relevance Evidence is insufficient for the use of cannabis or cannabinoids for most medical indications. Clear guidance from clinicians is essential to support safe, evidence-based decision-making. Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
英姑的应助被slk采纳,获得10
2秒前
华无剑的应助被zhe采纳,获得10
2秒前
空集发布了新的文献求助10
3秒前
小蘑菇的应助被李建勋采纳,获得10
3秒前
3秒前
3秒前
核桃发布了新的文献求助10
3秒前
Dugarrygana发布了新的文献求助10
4秒前
cjzj完成签到,获得积分10
6秒前
CAOHOU的应助被XZM采纳,获得10
6秒前
GJoey发布了新的文献求助10
6秒前
8秒前
8秒前
放青松完成签到,获得积分10
10秒前
10秒前
CodeCraft的应助被空集采纳,获得10
10秒前
11秒前
junyang发布了新的文献求助10
11秒前
苗条梨愁发布了新的文献求助50
11秒前
RONGGE完成签到 ,获得积分10
11秒前
12秒前
renn发布了新的文献求助10
12秒前
haorandu发布了新的文献求助10
13秒前
13秒前
13秒前
852的应助被闫玉坤采纳,获得10
14秒前
牧百川发布了新的文献求助10
14秒前
kuakuapizza完成签到 ,获得积分10
14秒前
molihuakai的应助被野性的苗条采纳,获得10
15秒前
yyychenn发布了新的文献求助10
15秒前
cruise发布了新的文献求助10
15秒前
情怀的应助被lsq108采纳,获得10
15秒前
乾隆发布了新的文献求助10
15秒前
16秒前
Akim的应助被even采纳,获得10
16秒前
fzh完成签到 ,获得积分10
16秒前
D515发布了新的文献求助10
16秒前
蓝草完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183894
求助须知:如何正确求助?哪些是违规求助? 9573067
关于积分的说明 21829226
捐赠科研通 7780983
什么是DOI,文献DOI怎么找? 3434150
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480648